Jump to content


Photo

xenograft tumor growth/kill modeling

TGI TSC jumbe

  • Please log in to reply
3 replies to this topic

#1 18963422692

18963422692

    Newbie

  • Members
  • Pip
  • 6 posts

Posted 15 May 2023 - 09:04 AM

Dear Useers,
   The mouse xenograft PK/PD relationship was established by relating mouse PK concentration to measured xenograft tumor volume data using an optimized cell distribution transduction model . The presented model is a modifified version of the model by Simeoni et al.(Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Res. 2004;64(3):1094101.)and Alison  et al.(A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART®).
 
    
Why is TSC less than 0 in my model?How can I optimize my model?
.

 Any suggestion?

 

Thank you

Attached Files


  • MiltonBluer likes this

#2 bwendt@certara.com

bwendt@certara.com

    Advanced Member

  • Administrators
  • 282 posts

Posted 15 May 2023 - 09:27 AM

Hi,

 

TSC is less than 0 simply because kmax is smaller than lambda0.

You can get around this by estimating parameter k2.

I don't have the reference for this specific adaption of the Simeoni model therefore can't check the code in detail.

 

Bernd



#3 18963422692

18963422692

    Newbie

  • Members
  • Pip
  • 6 posts

Posted 15 May 2023 - 09:37 AM

  See the attachment for the literature.

How to set parameter k2?

Attached Thumbnails

  • 2023-05-15_173516.jpg


#4 bwendt@certara.com

bwendt@certara.com

    Advanced Member

  • Administrators
  • 282 posts

Posted 16 May 2023 - 10:05 AM

I have looked at the model and the data and I got two observations:

 

1. there are perhaps too many parameters to estimate from the data. One thing that you could do is to use the unperturbed data to identify the growth parameters. Once estimated you can freeze those before you start estimating drug potency parameters

2. the potency of you drug candidate is not high. When you look at the curves you can see that the growth is shrinking, but the drug is not potent enough to bend the growth curve and actually shrink the tumor volume. During the study period the tumor volume is not reaching a plateau, so some parameters cannot be estimated

 

In summary, I would suggest you start with a simpler model and look at the unperturbed data first.

 

Bernd







Also tagged with one or more of these keywords: TGI, TSC, jumbe

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users